Vimarsana
Biggest News Aggregation in the World

Page 7 - Use Listing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Use Listing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Use Listing Today - Breaking & Trending Today

Five takeaways from WHO's immunisation advisory committee | Gavi, the Vaccine Alliance - Vimarsana News

Five takeaways from WHO's immunisation advisory committee | Gavi, the Vaccine Alliance

Last week WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization met to discuss COVID-19 boosters, monkeypox, Ebola, polio and measles, among other concerns. Here’s what they decided.

Source: gavi.org
Bharat Biotech completes phase 3 trial of intranasal Covid vaccine - Vimarsana News

Bharat Biotech completes phase 3 trial of intranasal Covid vaccine

Bharat Biotech has completed the clinical development for phase III trials and booster doses for BBV154 intranasal Covid-19 vaccine.   

Bharat Biotech completes clinical trial for nasal Covid-19 vaccine - Vimarsana News

Bharat Biotech completes clinical trial for nasal Covid-19 vaccine

Chairman and MD of Bharat Biotech Dr Krishna Ella said that the data analysis is going on for the world's first nasal Covid vaccine.

FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older - Vimarsana News

FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older

Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the first protein-based COVID-19 vaccine available in the U.S. GAITHERSBURG, Md., June 8, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the U.S. Food and Drug Administration (FDA) Vaccines and Related Biologica...

FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older - Vimarsana News

FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older

GAITHERSBURG, Md., June 7, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing